Sierra Oncology Reports 2020 Year End Results
Sierra Oncology Reports 2020 Year End Results News provided by Share this article Share this article – MOMENTUM Phase 3 Trial on Track to Complete Enrollment in mid-2021 with Top-line Data Anticipated in H1 2022 – – Data Presented Throughout the Year Included Long-Term Overall Survival, Efficacy in Various Patient Subsets and Dosing Durability – – Key Appointments Made to Executive Team in Preparation for Commercial Execution – SAN MATEO, Calif., March 11, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted thera...
Source: prnewswire.com